NUOVI FARMACI NELLA TERAPIA DELL'EPILESSIA DELL'INFANZIA: VIGABATRIN (STUDIO DI 61 SOGGETTI)

Translated title of the contribution: Emerging antiepileptic drugs: Vigabatrin (study of 61 children)

U. Raucci, A. Spalice, L. A. Basile, C. Guardala, L. Nasta, S. Terenzi, P. Iannetti

Research output: Contribution to journalArticlepeer-review

Abstract

This study was conducted to determine the efficacy of vigabatrin in children with epilepsy. Sixty-one children with various types of severe epilepsy were studied. In 12 children vigabatrin was introduced as monotherapy, while in 49 it was added to other antiepileptic drugs. Following the introduction of vigabatrin, 17 patients became seizure free, and 19 responded with a greater than 50% reduction in seizure frequency. The following types of epilepsy responded favorably to treatment (in order of decreasing efficacy): West syndrome, especially if secondary to Tuberous Sclerosis; cryptogenic and symptomatic partial epilepsy; Lennox-Gastaut syndrome, and other symptomatic generalized epilepsy. Optimal responses were found with vigabatrin doses of 30 to 50 mg/kg/day. Forty-one responders continued on vigabatrin, with generally good efficacy. Vigabatrin tolerability was good; in only 6 children was treatment discontinued because of side-effects such as somnolence, irritability, weight gain, and cutaneous rash. This study shows that vigabatrin is effective in the treatment of refractory epilepsy, especially in West syndrome secondary to Tuberous Sclerosis, partial epilepsy, and Lennox-Gastaut syndrome. Further studies are needed to analyze the increased frequency of seizures and the appearance of new seizure types associated with vigabatrin treatment.

Translated title of the contributionEmerging antiepileptic drugs: Vigabatrin (study of 61 children)
Original languageItalian
Pages (from-to)575-578
Number of pages4
JournalPediatria Medica e Chirurgica
Volume16
Issue number6
Publication statusPublished - 1995

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Fingerprint Dive into the research topics of 'Emerging antiepileptic drugs: Vigabatrin (study of 61 children)'. Together they form a unique fingerprint.

Cite this